Targeting IL-17 and TH17 cells in chronic inflammation
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
The key role of interleukin-17 (IL-17) and T helper 17 (T(H)17) cells in tissue inflammation, autoimmunity and host defence led to the experimental targeting of these molecules in mouse models of diseases as well as in clinical settings. Moreover, the demonstration that IL-17 and T(H)17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-T(H)17 cell pathway is regulated by IL-23, prompted the identification of inhibitors. These inhibitors include biotechnology products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A. Several clinical trials of these inhibitors are underway, and positive results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis. This Review focuses on the current knowledge of the IL-17-T(H)17 cell pathway to better understand the positive as well as potential negative consequences of targeting them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abs against IL-17/IL-17RA are in clinical trials for other autoimmune conditions [55].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [55]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Research works printed but not linked: 1
- Baeten, D. et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 62, Abstract L3847 (2010).
Cited by
Items 901–1,000 of 1,000
Silencing RORγt in Human CD4+ T cells with CD30 aptamer-RORγt shRNA Chimera
Shi, X., Song, P., Shao, T., Zhang, X., & Chu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46855-9 · Cited by 10
Mlambo, T., Tshabalala, M., Bandason, T., Mhandire, K., Mudenge, B., & Zijenah, L. S. (2019) · The Open AIDS Journal · doi:10.2174/1874613601913010059 · Cited by 10
Soltanmoradi, S., Tavakolpour, V., Moghadasi, A. N., & Kouhkan, F. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577602 · Cited by 12
Han, L., Shi, C., Zeng, X. L., Cen, L., Mei, X., Fan, J., Ju, D., & Zhu, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727941 · Cited by 10
Zhang, M., Zhao, H., & Gao, H. (2022) · Viral Immunology · doi:10.1089/vim.2021.0174 · Cited by 10
“Th17 cells and Tc17 cells contributed to either protective or pathologic immune response, which might be a context-dependent manner owing to the secretion of IL-17 and IL-22 (3,23,31,49).”
Han, X., Han, J., Wang, N., Ji, G., Guo, R., Li, J., Wu, H., Ma, S., Fang, P., & Song, X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.891670 · Cited by 10
“As another differentiated subtype of CD4+ T cells, Th17 cells mainly produce the cytokine interleukin-17 (IL-17) (Miossec and Kolls, 2012).”
BackgroundHu, D., Lin, Z., Jiang, J., Li, P., Zhang, Z., & Yang, C. (2022) · BioMed Research International · doi:10.1155/2022/4740141 · Cited by 11
“In addition, IL-17 activates the function and production of MMPs during chronic inflammation [46].”
Noack, M., & Miossec, P. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02904-9 · Cited by 10
Self-citationShah, A. M., Zamora, R., & Vodovotz, Y. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1599 · Cited by 14
Effects of kynurenine on CD 3+ and macrophages in wound healing
Elizei, S. S., Poormasjedi‐Meibod, M., Li, Y., Jalili, R. B., & Ghahary, A. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12252 · Cited by 14
Goldstein, O., Mandujano-Tinoco, E. A., Levy, T., Talice, S., Raveh, T., Gershoni‐Yahalom, O., Voskoboynik, A., & Rosental, B. (2021) · Marine Drugs · doi:10.3390/md19080454 · Cited by 10
“IL-17 acts as a key regulatory cytokine, and its upregulation results in tissue damage due to excessive inflammation, chronic inflammation [83], autoimmunity [84], and chronic GVHD in higher vertebrates [85].”
BackgroundWoodruff, P. G., Bhakta, N. R., & Fahy, J. V. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00041-5 · Cited by 17
Hall, A. O., Towne, J. E., & Plevy, S. E. (2018) · Nature Immunology · doi:10.1038/s41590-018-0141-z · Cited by 11
Exploring T Cell and NK Cell Involvement in Ankylosing Spondylitis Through Single‐Cell Sequencing
Chen, T., Ning, S., Zhu, J., Zhan, X., Zhou, C., Huang, C., Wu, S., Zhang, B., Feng, S., Chen, J., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70206 · Cited by 9
Giant-Cell Arteritis: Immunopathogenic Mechanisms Involved in Vascular Inflammation and Remodeling
Planas‐Rigol, E., & Corbera‐Bellalta, M. (2016) · Journal of Vasculitis · doi:10.4172/2471-9544.100103 · Cited by 9
“IL-17A is a highly pro-inflammatory cytokine with pleiotropic effects on a variety of cells including macrophages, neutrophils, endothelial cells and fibroblasts and actively contributes to inflammatory cascades [37].”
BackgroundAbdel‐Azim, H., Dave, H., Jordan, K. R., Rawlings-Rhea, S. D., Luong, A., & Wilson, A. L. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.08.007 · Cited by 9
Insulin-binding protein-5 down-regulates the balance of Th17/Treg
Zhu, M., Han, H., Hu, L., Cao, Y., & Fan, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019248 · Cited by 10
“IL−17 and Th17 cells are considered to be potential targets for the treatment of several inflammatory and autoimmune diseases (5).”
BackgroundWang, R., Qian, J., Ji, D., Liu, X., & Dong, R. (2023) · Animals · doi:10.3390/ani13030449 · Cited by 12
“IL-17 is a proinflammatory cytokine specifically secreted by helper T cells that can induce the secretion of early immune mediators [46,47].”
BackgroundMaity, S., Santra, A., Hebbani, A. V., Pulakuntla, S., Chatterjee, A., Badri, K. R., & Reddy, V. D. (2023) · Gene · doi:10.1016/j.gene.2023.147612 · Cited by 10
Song, G., Zhang, Y., Gao, H., Fu, Y., Chen, Y., Yin, Y., & Xu, K. (2024) · Genes · doi:10.3390/genes15020205 · Cited by 9
“…NF-κ B, which triggers the expression of proinflammatory cytokines and chemokines [21,22]. expression of proinflammatory cytokines and chemokines [21,22 Our study found that the level of IL-17 in the spleen of Ningxiang pigs is significantly higher Our study found that the level of IL-17 in the…”
BackgroundLi, Y., Xu, T., Zhao, Y., Zhang, H., Liu, Z., Wang, H., Huang, C.-Y., Shu, Z., Gao, L., Xie, R., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02304 · Cited by 9
Are peptidomimetics the compounds of choice for developing new modulators of the JAK-STAT pathway?
Cugudda, A., Manna, S. L., & Marasco, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1406886 · Cited by 9
“Different IL-17 proteins are linked to distinct biological activities i.e. IL-17A is associated with chronic obstructive pulmonary disease (COPD), while IL-17F in psoriasis and rheumatoid arthritis (50, 51).”
BackgroundMesenchymal stem cells alleviate inflammatory responses through regulation of T-cell subsets
Ji, W., Sun, L. Y., Wang, D., & Zhu, W. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176996 · Cited by 10
Zhang, Y., Su, X., Li, Y., Cai, Y., Kang, N., Duan, J., Chen, F., Xue, F., & Chen, X. (2024) · Journal of Periodontology · doi:10.1002/jper.23-0720 · Cited by 9
Pan, D., Xia, J., Qu, Y., Shi, C., Du, H., Zhang, J., Peng, F., Wang, X., Liu, R., Wu, L., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114459 · Cited by 9
Shen, Z., Zhang, C., Zhou, Z., Liu, W. X., Shi, L., & Shen, X. (2016) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2016.07.005 · Cited by 9
Mateen, S., Saeed, H., Moin, S., Khan, A. Q., & Owais, M. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105675 · Cited by 9
Campanati, A., Orciani, M., Marani, A., Vincenzo, M. D., Magi, S., Gregoriou, S., Diotallevi, F., Martina, E., Radi, G., & Offidani, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164759 · Cited by 10
Jaggi, U., Matundan, H. H., Lee, D. H., & Ghiasi, H. (2022) · Journal of Virology · doi:10.1128/jvi.01401-22 · Cited by 9
Dong, S., Wang, P., Zhang, X., Zhang, X., Li, X., Wang, J., Cui, X., Lan, T., Gao, C., Shi, Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117109 · Cited by 9
Smoking Enhances the Proinflammatory Effects of Nucleotides on Cytokine Release from Human Lung
Belchamber, K. B. R., Hall, D. A., & Hourani, S. M. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099711 · Cited by 9
Sun, B., Gao, J., Shi, W., Guo, Y., Fan, J., Zhang, J., Li, X., & Liu, G. (2019) · Pharmacogenomics · doi:10.2217/pgs-2018-0198 · Cited by 9
Jastrząb, B., Paśnik-Chwalik, B., Konopka, T. P., Krajewski, P. K., Szepietowski, J. C., & Matusiak, Ł. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237065 · Cited by 9
“Moreover, IL-17 may enhance the synthesis of matrix metalloproteinases in endothelial cells, epithelial cells, and fibroblasts, resulting in the destruction of connective tissue as well as the underlying bone [34].”
BackgroundIncreased Expression of IL-23 Receptor (IL-23R) in Vogt–Koyanagi–Harada (VKH) Disease
Wang, C., Wang, L., Hu, J., Li, H., Kijlstra, A., & Yang, P. (2018) · Current Eye Research · doi:10.1080/02713683.2018.1485952 · Cited by 9
Effects of RORγt overexpression on the murine central nervous system
Sasaki, T., Nagata, R., Takahashi, S., & Takei, Y. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12162 · Cited by 13
“3.1 | Elevated levels of Rorc and IL17A mRNA and serum IL- 17A in RORγt Tg mice Th17 cells are constitutively present in lamina propria of the gut16,17 and differentiate from naive T cells upon stimulation with IL- 6 and TGF- β18. mRNA levels of Rorc (the gene encoding RORγt) and IL17A were determined by qPCR and comp…”
BackgroundInfluentialLiu, Y., Li, L., Sun, Y., Wang, S., Jiang, P., Chen, Q., Zhang, L., Hao, Z., Yang, X., Yan, J., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119458 · Cited by 8
Guo, Q., Chen, W., Sun, J., Zhao, C., Bai, X., Zhang, Y., Liu, K., Zhang, L., & Shao, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1117545 · Cited by 9
Expression of Interleukin 17A and 17B in Gingival Tissue in Patients with Periodontitis
Mazurek−Mochol, M., Serwin, K., Bonsmann, T., Kozak, M., Piotrowska, K., Czerewaty, M., Safranow, K., & Pawlik, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144614 · Cited by 8
“IL-17 is mainly produced by Th-17 cells; however, the expression of this cytokine was also found on other immune cells such as neutrophils and natural killer cells [9,10].”
BackgroundLiu, G., Liu, X., Wang, F., Jia, G., Zhao, H. Y., Chen, X., & Wang, J. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.02.014 · Cited by 8
Pan, W., Cheng, J., Cao, X., Zheng, Y., Yang, Z., Feng, W., Chen, Y., & Wu, R. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.07.001 · Cited by 19
“The downregulation of the IL-17 pathway signifies a mitigation of inflammation [57].”
BackgroundRodríguez-Míguez, Y., Lozano-Ordaz, V., Ortiz-Cabrera, A. E., Barrios‐Payán, J., Mata‐Espinosa, D., Huerta‐Yépez, S., Baay-Guzman, G. J., & Hernández‐Pando, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307307 · Cited by 8
Altaca, M., Cebesoy, E. I., Kocak-Oztug, N. A., Bingül, İ., & Çifçibaşı, E. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04751-3 · Cited by 8
Louis, K., Tabib, T., Macedo, C., Wang, J., Cantalupo, P. G., Chandran, U. R., Gu, X., Lucas, M., Randhawa, P. S., Abundis, M., et al. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.10.009 · Cited by 9
Chakraborty, C., Bhattacharya, M., Das, A., & Saha, A. (2025) · Reviews in Medical Virology · doi:10.1002/rmv.70026 · Cited by 8
Analysis of cytokine release assay data using machine learning approaches
Xiong, F., Janko, M., Walker, M., Makropoulos, D., Weinstock, D., Kam, M., & Hrebien, L. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.024 · Cited by 9
“IL-17 is thought to be important in chronic inflammatory conditions such as autoimmune diseases, transplantation, and infections [53,54].”
BackgroundTargets of monoclonal antibodies for immunological diseases
Yoo, S. M., & Chung, S. H. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1087-2 · Cited by 9
Grigsby, K. B., Savarese, A. M., Metten, P., Mason, B. J., Blednov, Y. A., Crabbe, J. C., & Ozburn, A. R. (2020) · Neuroscience Insights · doi:10.1177/2633105520975412 · Cited by 8
“(k) Week 3: a two-way ANOVA (dose × sex) revealed no significant effects for 4-hour ethanol intake on Day 4 (F’s(1-2,65) < 1.”
MethodTan, Y.-Y., Ding, Y., Zheng, X., Dai, G.-J., Zhang, S., Xu, Y., Xu, D., Chen, P., Zhang, J., Ma, J., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10802 · Cited by 9
“Mature Th17 cells can express a variety of effectors molecules, including IL‐17, TNF‐α, IL‐17A and other cytokines (42,43).”
BackgroundWatabe, Y., Taguchi, K., Sakai, H., Enoki, Y., Maruyama, T., Otagiri, M., Kohno, M., & Matsumoto, K. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.11.011 · Cited by 8
Th17 cell differentiation induced by cytopathogenic biotype BVDV-2 in bovine PBLCs
Li, Y., Liu, T., Chen, G., Wang, L., Guo, A., Li, Z., Li, P., Li, M., & Luo, X. (2021) · BMC Genomics · doi:10.1186/s12864-021-08194-w · Cited by 8
Wang, C., Gao, H., Huang, L., Wang, Z., & Ding, X. (2022) · BioMed Research International · doi:10.1155/2022/5616942 · Cited by 8
“In addition, IL-17 is involved in epithelial cell and neutrophil-mediated immune responses against extracellular microbes and autoimmune diseases ’ pathogenesis [39, 40].”
The Mechanism of IL-17 Regulating Neutrophils Participating in Host Immunity of RVVC Mice
Shao, M., Hou, M., Li, S., & Qi, W. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01291-z · Cited by 9
“IL-17 has been confirmed to be involved in various pathological processes such as tissue inflammation, autoimmunity, and host defense [22] and has become a research hotspot for therapeutic targets for many diseases [23, 24].”
BackgroundZendejas-Hernandez, U., Alcántara-Martínez, N., Vivar, D. T., Valenzuela, F., Sosa-Espinoza, A., & Ceballos, E. E. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282280 · Cited by 10
Neurocognitive Impairment as One Facet of Cancer-Related Sickness Behavior Symptoms
Low, C. A., Kaliński, P., & Bovbjerg, D. H. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv176 · Cited by 10
“Additional options may include targeting IL-1 and IL-6, both known to promote Th17 immunity (18), involved in multiple aspects of neuropathology (19).”
BackgroundNo, D. J., Amin, M., Bhutani, T., & Wu, J. J. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1402116 · Cited by 9
“Tumor necrosis factor (TNF)-alpha and IL-22 are other key cytokines secreted by Th17 cells (6,7).”
BackgroundInfluentialInterleukine 17 et l’inflammation chronique : de la découverte au ciblage thérapeutique
Miossec, P. (2016) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30685-5 · Cited by 15
“Ces interactions synergiques entre IL-17 et TNFα justifient le ciblage simultané de l’IL-17 et du TNFα par un seul ou 2 inhibiteurs, avec un intérêt potentiel chez les patients non ou peu répondeurs aux anti-TNFα [2].”
BackgroundSelf-citationDesign and Synthesis of Conformationally Constrained RORγt Inverse Agonists
Sato, A., Fukase, Y., Kono, M., Ochida, A., Oda, T., Sasaki, Y., Ishii, N., Tomata, Y., Fukumoto, S., Imai, Y. N., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900416 · Cited by 9
BAP31 affects macrophage polarization through regulating helper T cells activation
Yuan, Q., Niu, K., Sun, L., Zhao, B., Wang, X.-Y., & Wang, B. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10095-5 · Cited by 9
“Th17 cells (transcription factor RORγt) secrete IL-17 and recruit granulocytes to combat extracellular microorganisms (Miossec & Kolls, 2012; Nomura et al. 2014).”
BackgroundSimon, D. W., Raphael, I., Johnson, K. M., Dixon, C. E., Vagni, V., Janesko‐Feldman, K. L., Kochanek, P. M., Bayır, H., Clark, R. S. B., & McGeachy, M. J. (2022) · Neurotrauma Reports · doi:10.1089/neur.2022.0017 · Cited by 10
“In the CNS, major sources of IL-17 include T-helper 17 (Th17) cells and cd-T cells and minor sources include astrocytes, microglia, and tissue-resident macrophages.(7,8) Translational studies have established a key role of IL-17 and IL-17-producing T lymphocytes in the pathophysiology of multiple sclerosis (MS), strok…”
BackgroundAct1-hsp90 heats up TH17 inflammation
Kumar, P., & Kolls, J. K. (2012) · Nature Immunology · doi:10.1038/ni.2498 · Cited by 8
Self-citationClimate Change Impact on Immune Response in Sheep
Caroprese, M., Ciliberti, M. G., Albenzio, M., & Sevi, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-4714-5_4 · Cited by 9
Wang, W. J., Liu, W., Liu, J., Wang, Z., Fan, F., Ma, Y., Jin, C., Xiang, Y., Huang, Y., Zhang, X., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00438-17 · Cited by 8
“logical and dermatological diseases (27).”
The Role of Th17 Cells in Immunopathogenesis of Neuroinflammatory Disorders
Pourgholaminejad, A., & Tahmasebinia, F. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_3 · Cited by 9
Cai, J., Wang, F., & Shi, S. (2024) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12918 · Cited by 7
The relationship between interleukin and ankylosing spondylitis
Zhu, Z., Wang, H., Wang, X., Zhao, Y., Mei, X., & Liu, J. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156968 · Cited by 8
CD4+ T cell membrane-based nanocomposites for enhanced dual epigenetic therapy in psoriasis
Hou, L., Wang, N., Miao, Q., Wang, Z., & Yan, F. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.05.067 · Cited by 7
Matera, M., Biagioli, V., Illiceto, M. T., Palazzi, C. M., Cavecchia, I., Manzi, A., Lugli, S., Pennazzi, L., Meocci, M., Pedaci, F. A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1726630 · Cited by 7
“Through these signaling cascades, IL-17 regulates the expression of pro-in fl ammatory cytokines (IL-6, TNF-a , IL-1 b ), chemokines, and matrix metalloproteinases, amplifying the local in fl ammatory response and sustaining tissue injury (40, 41).”
Th17 Cells: Orchestrators of Mucosal Inflammation and Potential Therapeutic Targets
Iraji, D., Oftedal, B. E., & Wolff, A. S. B. (2023) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023050360 · Cited by 7
Tanaka, H., Hasebe, R., Murakami, K., Sugawara, T., Yamasaki, T., & Murakami, M. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00126-1 · Cited by 8
“Activated T H 17 cells highly secrete proinflammatory cytokines, including IL-17, TNF-α and IL-6, which contribute to the inflammatory response of nonhemat-opoietic cells by synergistically amplifying inflammation in combination with the simultaneous activation of STAT3 and NFkB (Ogura et al. 2008; Shen et al. 2006).”
BackgroundInfluentialThe Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis
Chen, Y., Liu, W., Xu, X., Zhen, H., Pang, B., Zhao, Z., Zhao, Y., & Liu, H. (2024) · Inflammation · doi:10.1007/s10753-024-02002-9 · Cited by 7
“Furthermore, over-differentiation of Th17 cells can lead to elevated levels of pro-inflammatory cytokines, such as IL-17A [5], resulting in bone and joint damage as well as pain for patients with AS [50, 51].”
Li, S., Chao, H., Li, Z., Chen, S., Zhang, J., Hao, W., Zhang, S., Liu, C., & Liu, H. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07589-6 · Cited by 7
“…with male patients, which means that female AS patients tend to have a lower degree of inflammation and slower imaging progression These observations implicate a sex bias in the immunopatho-genesis of AS. IL-17-secreting cells, which producing IL17, contribute to the pathogenesis of AS [12].”
Zhou, Y., Yu, Z., & Lu, Y. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123556 · Cited by 10
Palazzo, E., Lotti, R., Quadri, M., Pincelli, C., & Marconi, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072989 · Cited by 7
Barnet, M. B., Jackson, K., Masle‐Farquhar, E., Russell, A., Burnett, D. L., Chye, A., Jara, C., Faulks, M. L., Mawson, A., Peters, T. J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314258122 · Cited by 8
“…of IL23/IL17 signaling and has significant mechanistic overlap with NOD2 - associated inflammatory bowel disease despite minimal overlap of annotated risk SNPs ( 54 – 63 ), although in our cohort a lower polygenic risk for psoriasis and NOD2 LOF was associated with better cancer survival.”
A Review of Phase III and Long‐Term Data for Deucravacitinib for Plaque Psoriasis
Babaei, N., Kim, D., Cervantes, M., Yang, S., Gill, M., & Wu, J. J. (2025) · International Journal of Dermatology · doi:10.1111/ijd.70023 · Cited by 7
Георгиевна, Ч. Е., Urazova, O. I., Novitskiy, V. V., Евгеньевна, Е. И., Кононова, Т. Е., Filinyuk, O. V., Kolobovnikova, Y. V., & Дмитриева, А. И. (2016) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2016-5-166-177 · Cited by 7
Silva, M. S. D. L., Santos, J. D. A., Alves, A. J., da Silva, R. M. F., Santos, B. S., de Lorena, V. M. B., de Oliveira, G. G., de Melo, C. M. L., & Góes, A. J. D. S. (2019) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2019.01.010 · Cited by 7
“, 2012; Kimura and Kishimoto, 010; Hunter and Jones, 2015) which is important in inflammatory esponses and in defense against infections caused by extracellular icroorganisms (Miossec and Kolls, 2012; Misiak et al., 2017).”
BackgroundTome, S., Sasaki, T., Takahashi, S., & Takei, Y. (2019) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.19-0038 · Cited by 10
“Moreover, serum levels of IL-17A, the major cytokine released from Th17 cells [18], were consistently upregulated in RORγt Tg mice, suggesting that the alterations in E-cadherin expression were caused by IL17-mediated chronic immune responses.”
BackgroundInfluentialLi, C., Chu, T., Zhang, Z., & Zhang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656124 · Cited by 8
Zheng, S., Gu, H., Han, G., Xu, H.-L., Liu, Z., Lü, Y., & He, F. (2021) · Journal of Virology · doi:10.1128/jvi.01119-21 · Cited by 8
“IL-17 binds to the receptor to activate many downstream signals, such as NF-kB, mitogen-activated protein kinases (MAPKs), and CCAAT/enhancer binding protein (C/EBP), thereby modulating many target genes, such as IL-6, C/EBPd , and IkBz (42, 44).”
BackgroundNasonov, E. L., Avdeeva, A. S., Korotaeva, T. V., Дубинина, Т. В., & Usacheva, J. V. (2023) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2023-165-180 · Cited by 8
Qin, C., Yu, Q., Deng, Z., Zhang, Y., Chen, M., Wang, X., Hu, T., Lei, B., Yan, Z., & Cheng, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345416 · Cited by 9
Yang, Y.-N., Han, B., Zhang, M.-Q., Chai, N.-N., Yu, F.-L., Qi, W.-H., Tian, M., Sun, D.-Z., Huang, Y., Song, Q.-X., et al. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01472-5 · Cited by 8
“Interleukin-17 (IL-17) and T helper 17 (Th17) cells play a key role in tissue inflammation and autoimmunity (Miossec and Kolls 2012).”
Korayem, H. K., Rezk, M. M., Hassan, M. M., El-Tawab, S. S., & Elsaid, N. A. (2015) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2015.06.006 · Cited by 7
“Interleukin-17 contributes to cartilage and bone destruction by acting as a potent inductor of the expression of matrix metalloproteinases (MMPs) and receptor activator of nuclear factor (NF)-jb ligand (RANKL) in rheumatoid synoviocytes and osteoblasts, being an important promoter of osteoclastogenesis [10].”
BackgroundNa-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis
Langdon, K., Buitrago, G., Pickering, D., Giacomin, P., Loukas, A. C., & Haleagrahara, N. (2022) · Inflammopharmacology · doi:10.1007/s10787-021-00909-5 · Cited by 8
Carvalho, M. L. G., Falcão, L. F. M., Lopes, J. D. C., Mendes, C. C. H., Olímpio, F. A., Miranda, V. D. S. C., dos Santos, L. C., de de Moraes, D. D. P., Filho, M. V. B., da Costa, L. D., et al. (2022) · Cells · doi:10.3390/cells11132053 · Cited by 7
“In addition, during the cell formation process, cytokines such as IL-6 and TGF-β participate in the process of cellular differentiation, and transcription factors such as STAT3 and RORγ characterise their pro le signature [16, 17, 18].”
BackgroundMFG-E8, a novel homeostatic regulator of osteoclastogenesis
Hajishengallis, G. (2014) · Inflammation and Cell Signaling · doi:10.14800/ics.285 · Cited by 8
“Taken together with the strong connection between inflammation and osteoclastogenesis ([18]), our findings suggest that the therapeutic application of MFG-E8 is capable of a twopronged attack on periodontitis and perhaps other inflammatory bone disorders (e.”
BackgroundAcuff, N. V., Li, X., Latha, K., Nagy, T., & Watford, W. T. (2017) · Infection and Immunity · doi:10.1128/iai.00193-17 · Cited by 7
Gong, Y., Jia, H., Dang, W., Zhou, T., He, P., Wang, X., & Zhu, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1490003 · Cited by 8
“The results indicated that the TP/GPS group had a higher number of IFN-g , IL-2, and IL-17A producing CD4 + T cells than PBS, BCG, and TP groups.”
InfluentialWang, W., Cheng, M., Dai, R., Chen, Y., Wei, L., Sang, Y., Gao, Y., Liu, F., Wang, Y., & Zhang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178062 · Cited by 6
The IL-17 axis in gastric carcinogenesis: From inflammation to oncogenic transformation
Lyu, Z., Gu, M., Lu, Z., Lin, F., Zhang, R., Dong, P., Liu, Y., Li, Z., & Huang, L. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.12.001 · Cited by 6
Liu, J., Li, Z., Peng, X., Zhao, W., Chu, T., Ju, J., Ren, J., & Gao, F. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106208 · Cited by 7
Akwo, A. U., Emily, R., Oyoo, O., & Mahamat, O. (2025) · Multidisciplinary Science Journal · doi:10.31893/multiscience.2026281 · Cited by 6
The Glymphatic System and Meningeal Lymphatics: Current Understandings and Future Perspectives
Sun, H., Fan, H., Zhou, Y., Zhu, H., Chen, Y., Zhang, R., Wang, K., Pan, Y., & Zhang, A. (2026) · MedComm · doi:10.1002/mco2.70691 · Cited by 6
Sunitinib displays pulmonary fibrosis in experimental rats: Role of IL-17A dependent pathway
Asker, M. E.-S., Abdelmeged, A. A., Shaheen, M. A., & Eissa, R. G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110173 · Cited by 6
Liu, P., Yu, X. H., Wang, J., Wang, L., Ding, Y., & Liu, J. (2023) · Animal Reproduction · doi:10.1590/1984-3143-ar2022-0106 · Cited by 6
Biologics as a novel treatment option for palmoplantar pustulosis: a comprehensive review
Leong, H. F., Wang, W., & Peng, F. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2024.141128 · Cited by 6
“Both IL-17A/F are produced by Th17 cells and play an essential part in epithelial defence processes [16].”
BackgroundZhou, Y. Y., Yang, M., Fu, R., Liu, W., Cai, Z., Lin, H., Li, S., Zong, C., Chen, Y., & Tong, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-69436-x · Cited by 7
“Since IL-17F uses the same IL-17RA and IL-17RC receptors for the downstream signaling, lots of functions of IL-17F and IL-17A were overlapped 39 .”
BackgroundJamshidi, S., Eskandari, Z., Ojaroodi, A. F., Keramat, S., & Stanek, A. (2025) · Nutrients · doi:10.3390/nu17142303 · Cited by 6
“Anthocyanidin , a flavonoid commonly found in red berries, has been shown to reduce inflammation in various diseases, including asthma, diabetes, atherosclerosis, and cancer, primarily due to its anti-inflammatory properties [151–155].”
Mamaklıoğlu, D., Karched, M., Kuru, L., Kuru, B. E., Asikainen, S. E., & Doğan, B. (2022) · International Journal of Dental Hygiene · doi:10.1111/idh.12592 · Cited by 6
Metadata
- Authors
- Miossec, P., & Kolls, J. K.
- Affiliations
- Lyon 1 Université (FR)
- University of Pittsburgh (US)
- Corresponding author
- Miossec, Pierre
- Kolls, Jay K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-10
- Volume
- 11
- Issue
- 10
- Pages
- 763-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2022917731
- Cited by
- 1,414
- References
- 169
- Citations by year
- 2026: 74 · 2025: 104 · 2024: 137 · 2023: 101 · 2022: 121 · 2021: 129 · 2020: 97 · 2019: 91 · 2018: 67 · 2017: 114 · 2016: 100 · 2015: 109 · 2014: 97 · 2013: 72 · 2012: 1
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- Institut Mérieux
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, IL-17 inhibitors, IL-23, IL-17 receptor A, psoriasis, rheumatoid arthritis, ankylosing spondylitis, chronic inflammation, autoimmunity, biologic therapy, IL-17A
- MeSH terms
- Animals, Chronic Disease, Humans, Inflammation, Drug Delivery Systems, Interleukin-17, Receptors, Interleukin-17, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.